Yakira Capital Management, Inc. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 52 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Yakira Capital Management, Inc. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$667,275
-15.4%
54,118
-15.6%
0.18%
-13.4%
Q2 2023$788,651
-11.0%
64,118
-11.1%
0.21%
-7.1%
Q1 2023$886,330
-9.8%
72,118
-15.9%
0.22%
+12.5%
Q4 2022$982,489
+126.4%
85,732
-26.0%
0.20%
+217.5%
Q3 2022$434,000
-37.0%
115,8210.0%0.06%
-41.7%
Q2 2022$689,000
+22.8%
115,821
+30.6%
0.11%
+35.0%
Q1 2022$561,000
+95.5%
88,683
+20.7%
0.08%
+122.2%
Q4 2021$287,000
-2.0%
73,450
+21.1%
0.04%
-20.0%
Q3 2021$293,000
-24.3%
60,6340.0%0.04%
-28.6%
Q2 2021$387,000
+1.6%
60,6340.0%0.06%
-18.2%
Q1 2021$381,000
-8.9%
60,6340.0%0.08%
-23.0%
Q4 2020$418,000
+56.0%
60,634
-9.4%
0.10%
+26.6%
Q3 2020$268,000
+20.2%
66,9340.0%0.08%
-21.0%
Q2 2020$223,000
+54.9%
66,9340.0%0.10%
+100.0%
Q1 2020$144,000
-31.8%
66,9340.0%0.05%
-19.4%
Q4 2019$211,000
-29.9%
66,9340.0%0.06%
-29.5%
Q3 2019$301,000
-25.7%
66,9340.0%0.09%
+11.4%
Q2 2019$405,000
-12.9%
66,9340.0%0.08%
-40.6%
Q1 2019$465,000
+80.2%
66,9340.0%0.13%
+52.9%
Q4 2018$258,000
-27.7%
66,9340.0%0.09%
+27.9%
Q3 2018$357,000
+8.5%
66,9340.0%0.07%
-15.0%
Q2 2018$329,000
-45.1%
66,934
-10.1%
0.08%
-41.6%
Q1 2018$599,000
-30.4%
74,434
-11.4%
0.14%
-50.7%
Q4 2017$861,000
+284.4%
83,969
+445.0%
0.28%
+270.7%
Q3 2017$224,00015,4070.08%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
22NW, LP 749,302$2,892,0001.80%
Clearline Capital LP 316,425$1,221,0000.84%
Newtyn Management, LLC 888,620$3,430,0000.67%
Western Standard LLC 150,363$580,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 222,467$859,0000.40%
BVF INC/IL 721,935$2,787,0000.36%
Sepio Capital, LP 411,676$1,589,0000.12%
Yakira Capital Management, Inc. 66,934$258,0000.09%
J. Goldman & Co LP 152,095$587,0000.04%
Spark Investment Management LLC 48,909$188,0000.01%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders